850: The antitumor agent obatoclax displays antimetastatic properties on melanoma cells in vitro and in vivo
Vanessa Soto‐Cerrato(Institut d'Investigació Biomédica de Bellvitge), Ricardo Pérez‐Tomás(Bellvitge University Hospital), Ananda M. Rodilla(Universitat de Barcelona), Cèlia Garcia‐Martínez, Margarita Espona‐Fiedler(Umeå University), Pilar Manuel-Manresa(Universitat de Barcelona), R. Quesada
Cited by 0
Related Papers
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma
|Modern Pathology|2014|174
Synthetic Prodiginine Obatoclax (GX15‐070) and Related Analogues: Anion Binding, Transmembrane Transport, and Cytotoxicity Properties
|Chemistry - A European Journal|2011|116
<scp>FLIP</scp> as a therapeutic target in cancer
|FEBS Journal|2018|86
Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life
|PLoS ONE|2015|76
Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax
|Biochemical Pharmacology|2011|74